داروسازیزهراوی
دزهراوی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 5,280 2.92
Close Price: 5,280
Income Statement
AGM
Interim
2026/06/20 Fiscal Year 2026/03/2012 Month | 2025/05/03 Fiscal Year 2025/03/2012 Month | 2024/07/09 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 15.203 Trillion | 9.132 Trillion | 6.217 Trillion | |
Total Revenues | 15.203 Trillion | 9.132 Trillion | 6.217 Trillion | |
Cost of Goods Sold | 8.948 Trillion | 5.965 Trillion | 3.807 Trillion | |
Gross Profit | 6.256 Trillion | 3.168 Trillion | 2.41 Trillion | |
General & Administrative Expenses | 1.529 Trillion | 1.128 Trillion | 745.741 Billion | |
Net Operating Income & Expenses | -178.547 Billion | -434.274 Billion | -436.3 Billion | |
Operating Profit (Loss) | 4.548 Trillion | 1.605 Trillion | 1.228 Trillion | |
Profit Before Tax | 4.045 Trillion | 737.881 Billion | 418.09 Billion | |
Tax | 846.513 Billion | 245.07 Billion | 414.632 Billion | |
Net Profit (Loss) After Tax | 3.198 Trillion | 492.811 Billion | 3.458 Billion | |
Retained Earnings at Beginning of Period | 232.072 Billion | -248.525 Billion | -251.983 Billion | |
Approved Dividends — Prior Year AGM | -160.2 Billion | - | - | |
Allocable Profit | 3.27 Trillion | 244.286 Billion | -248.525 Billion | |
Legal Reserve | 159.909 Billion | 12.214 Billion | - | |
Approved Dividends — Current Year | 1.553 Trillion | 160.2 Billion | - | |
Retained Earnings at End of Period | 1.558 Trillion | 71.872 Billion | -248.525 Billion |